About ZebiAI
ZebiAI is a company based in Waltham (United States) founded in 2019 by Richard Wagner was acquired by Relay Therapeutics in April 2021. ZebiAI operates in a competitive market with competitors including Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
- Headquarter Waltham, United States
- Founders Richard Wagner
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Relay Therapeutics
(Apr 16, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of ZebiAI
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of ZebiAI
Detailed funding history for ZebiAI
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in ZebiAI
ZebiAI has secured backing from 1 investor. Prominent investors backing the company include Relay Therapeutics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug discovery platform is developed to study protein motion.
|
Locked | Locked | Locked |
Investor details for ZebiAI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ZebiAI
Investment portfolio details for ZebiAI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ZebiAI
Detailed financials for ZebiAI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zebiai Comparisons
Peer comparison for ZebiAI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ZebiAI
ZebiAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Owkin, Formation Bio, AbSci, BigHat and Predictive Oncology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An agentic AI platform is developed for biomedical research insights.
|
|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
AI-based technology is used for recombinant protein production in therapeutics.
|
|
| Locked | Locked | Locked |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| Locked | Locked | Locked |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| Locked | Locked | Locked |
AI platform used for extracting antibody data from scientific papers.
|
Detailed competitors of ZebiAI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zebiai
Complete news archive for ZebiAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ZebiAI
ZebiAI was founded in 2019.
ZebiAI is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
ZebiAI was founded in 2019 and is based in Waltham, United States. Machine learning algorithms are utilized by the company to identify potential clinical candidate molecules and predict their pharmaceutical properties within the small molecule drug discovery sector. Operations focus on AI-driven tools for biotech and pharmaceutical applications. Partnerships are maintained with entities including X-Chem, Google, and SGC to support these efforts.
ZebiAI's top competitors include Owkin, Formation Bio and XtalPi.
ZebiAI has 1 investor. Key investors include Relay Therapeutics.